CompuGroup Medical updates its IR calendar, shares hover around 27 euros on Xetra

By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-23, 22:32.

CompuGroup Medical (DE000A288904) maintains an active investor relations calendar, with upcoming financial events and conference participations listed for shareholders on its Koblenz IR hub. The health IT specialist’s shares trade on Xetra in the upper 20s euros per finanzen100 data, underscoring its role in Germany’s listed software segment. finanzen100 overview of CompuGroup Medical

What the IR hub shows today

CompuGroup Medical’s investor relations page highlights scheduled releases and events, including future quarterly updates and capital market appearances for 2026, with details on formats and locations provided for each entry. CompuGroup Medical investor relations calendar The page also links to past reports and presentations, giving a continuous timeline of the group’s communication with equity investors.

The IR section structures information by financial period and event type, making it easier for Xetra-focused shareholders to track when results, guidance comments or conference talks will be released. Contact details for the investor relations team in Koblenz are listed with phone and email, providing a direct line for institutional and retail investors. IR service and contact information

Consensus and analyst coverage

Analyst platforms such as MarketScreener and finanzen.net report that CompuGroup Medical is followed by several European brokerages, with the majority of current recommendations clustering in the Buy and Hold ranges and target prices typically positioned above the mid-20s euro region. MarketScreener analyst consensus for CompuGroup Medical Individual houses, including Berenberg and Deutsche Bank in past updates, have focused primarily on digital health growth prospects and recurring revenue streams from software subscriptions.

The distribution of ratings across Buy, Hold and Sell is updated as new research comes in, and aggregated consensus data show a tendency for price targets to factor in continued digitalization in European healthcare IT. For investors, this provides a structured snapshot of how the sell-side currently assesses CompuGroup Medical’s margin profile and top-line growth trajectory. finanzen.net analyst reports on CompuGroup Medical

The health IT business behind the stock

CompuGroup Medical’s core business is providing software solutions and digital services for doctors, hospitals, pharmacies and other healthcare facilities. The group’s portfolio includes practice management systems, electronic medical records and e-health communication platforms that facilitate secure data exchange in everyday care settings. CGM MEDISTAR practice management software Revenues predominantly stem from license fees, maintenance and recurring subscriptions, giving the stock an exposure to long-term digitization trends in healthcare.

Where the CompuGroup Medical shares trade today

CompuGroup Medical shares (DE000A288904) trade on Xetra, with recent prints around 27 to 29 euros as indicated by finanzen100’s quote section. Latest Xetra price range for CompuGroup Medical The stock sits in Germany’s specialized software sector, making it a reference point for investors focused on listed e-health providers.

Disclaimer: This article is for informational purposes only and does not constitute investment advice, a recommendation to buy or sell securities, or a solicitation of any kind. All data and figures are based on publicly available sources believed to be reliable at the time of publication.